Rehabilitation of complex regional pain syndrome: Evidence based or trial and error? by McCabe, Candy
part of
147ISSN 1758-186910.2217/PMT.13.7 © 2013 Future Medicine Ltd Pain Manage. (2013) 3(2), 147–155
SUMMARY Complex regional pain syndrome (CRPS), a relatively rare condition, is 
commonly diagnosed late and has no known cause or cure. There is a limited evidence base 
for therapeutic interventions and the majority of patients make a spontaneous recovery. The 
florid signs and symptoms of early CRPS are diminished and altered in the more persistent 
treatment-resistant form. New signs and symptoms, not listed in diagnostic criteria, begin 
to emerge that can confuse both the patient and clinician, and lead to questioning of the 
diagnosis. Trying to implement timely and evidence-based rehabilitation techniques within 
the above scenario is a significant challenge. This article will discuss those challenges and 
consider recent clinical and research advances that have sought to address some of these 
problems in CRPS type I.
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  Rehabilitation of patients with complex regional pain syndrome (CRPS) requires a multidisciplinary 
approach to meet their complex biopsychosocial needs. 
  The rarity of CRPS and the rapid recovery of the majority of CRPS patients has hampered the conduct of 
robust clinical trials to define an evidence-based care pathway.
  The signs and symptoms of CRPS change over time, with new ones emerging in chronic CRPS that relate 
to progressive central mechanism changes. 
  Evidence-based data are limited on who should receive which intervention and when, but expert 
opinion recommends early diagnosis and prompt instigation of treatments.
  Future research should be focused on the identification of biomarkers for CRPS and the development of 
timely, tailored therapeutic packages of care. 
  Current international research and clinical consortia should be strengthened and developed to optimize 
future progress in this field. 
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Candida S McCabe*
Rehabilitation aims to restore the physical and 
psychosocial deficits that may have been incurred 
due to injury or disease and, as such, commonly 
requires a multidisciplinary approach. For 
individuals with complex regional pain syndrome 
(CRPS), early diagnosis and prompt instigation 
For reprint orders, please contact: reprints@futuremedicine.com
Pain Manage. (2013) 3(2) future science group148
Review McCabe
in its persistent, chronic form (incidence rates 
range from 5.46 to 26.2 per 100,000 person years 
[12,13]), the recruitment of large patient cohorts 
can be a substantial challenge. The problem is 
further compounded by the daily, or even hourly, 
fluctuation in signs and symptoms that many 
patients experience. Identifying the impact of 
a therapeutic intervention against a constantly 
changing clinical picture means controlled trials 
are essential. Furthermore, the multisystem 
nature of CRPS means that multimodal therapies 
are likely to deliver the optimum outcome, 
but conducting such complex interventions 
are resource intensive and methodologically 
daunting [14]. 
Clearly the ideal solution would be to identify 
those at risk of CRPS prior to onset, or very 
early in the condition, and prevent the escalation 
of signs and symptoms; thereby negating the 
need for rehabilitation at all. Current research 
is precisely focused on this, with the aim of 
identifying prognostic markers for CRPS, ideally 
prior to surgical interventions or immediately 
post-trauma [6]. To date there is no evidence of 
psychological predictors [15]; however, de Mos 
and colleagues found a significant association 
between CRPS and a prior diagnosis of migraine 
or osteoporosis in a cohort of 186 people with 
CRPS [16]. Other identified risk factors include 
immobilization of the limb post fracture [16], 
complaint of a tight plaster cast [17] and current 
use of angiotensin-converting enzyme inhibitors 
[18]. No robust genetic associations have been 
identified to date, but there is evidence of CRPS 
occurring more commonly in some families, 
thereby suggesting that genetics may play a role 
[19]. Further work with larger study cohorts is 
required to determine to what degree genetics 
contribute to the development of CRPS. 
In the absence of definitive prognostic indicators 
for CRPS, but with the recommendation of 
treating CRPS promptly to optimize outcome, 
early identification of the signs and symptoms 
is essential. 
Identifying the signs & symptoms of 
early & persistent CRPS to instigate 
rehabilitation
Patients with CRPS are encountered within a 
diverse range of primary and secondary care 
settings [3], but are most commonly seen within 
orthopedic and pain clinics as the condition 
is usually triggered by trauma to a limb, most 
commonly a fracture [13]. Disturbances in sensory, 
of rehabilitation is now widely recommended 
as the best way to achieve optimum patient 
outcomes [1–3]. This is clear, definitive guidance 
and intuitively feels correct; however, in clinical 
practice, CRPS is commonly underdiagnosed 
[4,5]. Patients describe a delay in diagnosis and 
a wide variety of interventions throughout a 
meandering pathway of care that may, or may 
not, result in a patient-perceived satisfactory 
outcome. This discrepancy between ‘desired’ and 
‘actual’ care may arise due to a number of factors, 
including poor recognition of this relatively rare 
condition by healthcare professionals. However, 
even when CRPS is accurately diagnosed there 
is a lack of high-quality evidence to define the 
precise content, frequency and timing of a 
rehabilitation intervention after symptom onset. 
The challenge of designing & evaluating 
rehabilitation interventions in CRPS
In order to specify an accurate and effective 
intervention, it is important to know the cause 
and course of a condition. Unfortunately, 
neither of these are clear in CRPS; the exact 
cause of the condition is unknown and its 
trajectory varies between and within individuals 
with no definition of recovery to measure 
improvement against. 
CRPS is acknowledged to be a multisystem 
syndrome that involves aberrant changes in 
vasomotor function, inflammatory mechanisms 
and cortical processing [6]. These changes are 
probably initially triggered by a peripheral insult 
that quickly evolves into a centrally driven 
condition for which there is currently no cure [6,7]. 
For the vast majority of patients, symptoms resolve 
in a matter of months and by 1 year, as many as 
80–85% of patients may be asymptomatic, as 
recorded in a postfracture cohort [8]. However, 
the remaining 15–20% continue to experience 
disabling symptoms and are commonly left 
with long-term functional impairments, as 
well as the psychosocial impact of chronic pain 
[9–11]. This lack of clarity on the cause of the 
syndrome, and the natural rapid recovery from the 
condition for many patients, means that targets 
for rehabilitation in early CRPS are difficult to 
identify and evaluate in terms of efficacy or need. 
By the time the condition has lasted for more 
than 1 year and proven to be treatment resistant 
or chronic, the potential for interventions to 
provide significant health benefits is reduced, and 
therefore population sizes for clinical trials need to 
be large. In a relatively rare condition, especially 
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motor and autonomic pathways are normally 
present in a single limb; although they may occur 
in multiple limbs and other body regions [20–22]. 
The degree to which these disturbances occur will 
vary between patients and fluctuate on a daily, or 
even hourly, basis within individuals. CRPS is 
defined as either CRPS type I or II depending 
on the presence (II) or absence (I) of identifiable 
nerve damage (Table 1) [23]. Similar therapeutic 
approaches are used for both types, although only 
type II meets the criteria for a neuropathic pain 
condition [24]. This article focuses on CRPS type I.
In the early stages, the patient commonly 
complains of severe burning pain and the limb 
is edematous, with the skin shiny and mottled in 
color (Figure 1). The affected limb may feel warm 
or cool to touch, and may be sweaty in appearance 
with either excessive or reduced hair and nail 
growth. The patient is extremely protective of the 
limb and is reluctant for any touch to it, including 
clothing or bed covers at night [25]. Movement 
of the limb is likely to be painful and there may 
also be evidence of tremor, reduced quality of 
movement and a delay in instigating movements 
[25,26]. Patients often have a strong dislike of the 
limb, reduced ownership and disturbances in 
perceived size and shape of the limb [27–29]. As 
well as these disturbances in body perception, the 
clinician may be able to elicit referred or double 
sensations when touching the limb, or the area 
adjacent to the limb, on the somatosensory cortex 
[30,31]. For example, touch to a CRPS left hand 
may evoke a perception of touch to the left side 
of the face, or touch to a CRPS foot evokes a 
similar sensation on the ipsilateral knee. Referred 
sensations can be a bidirectional phenomenon 
and are usually modality specific. Approximately 
one-third of patients with CRPS have been shown 
to exhibit referred sensations that are lost as the 
condition resolves [30]. These findings, and reports 
of body perception disturbances, are considered to 
be indicative of the neuroplastic changes known 
to occur in the somatosensory cortical maps in 
CRPS and other chronic pain conditions [32,33]. 
Imaging data have demonstrated a reduction in 
the representation of the CRPS-affected body 
part on the primary sensory cortex and increased 
activity in the representational motor area [33,34]. 
A direct correlation has been demonstrated 
between the extent of cortical reorganization and 
the level of pain perceived in CRPS, with pain 
reducing as the changes on the somatotopic and 
somatosensory maps start to reverse [35,36]. 
In its early form, the florid signs and symptoms 
of CRPS make it relatively easy to diagnose, but in 
its chronic form this becomes more problematic 
(Figure 2). Over time, the edema usually reduces, 
hair growth returns to a more normal pattern and 
color changes may be less apparent. However, the 
level of disability may increase due to a spread in 
the extent and intensity of allodynia, the negative 
impact on psychosocial function from living with 
chronic pain [9,10] and a progression in motor 
problems [20]. The usually flexed postures of a 
CRPS dystonia occur in approximately 25% of 
all patients with a distal-to-proximal spread of 
limb contracture [37]. When dystonia is present, 
functional rehabilitation can be particularly 
challenging and may consequently indicate a poor 
outcome [38]. Muntts and colleagues have recently 
identified evidence of thermal hypesthesia (both 
hot and cold) in this dystonic patient group [39]; 
however, to date, the etiology behind these motor 
and sensory changes can only be postulated at, 
and appear to involve both peripheral and central 
mechanisms [26,39]. Whether evidence of thermal 
hypesthesia in the early stages of CRPS could be 
used as a prognostic marker for dystonia is not 
yet known, currently; quantitative sensory testing 
has not identified a unique CRPS pattern versus 
other neuropathic pain conditions [40]. However, 
there is evidence that those with CRPS have a 
reduced threshold to tactile stimulation, pressure 
and heat pain [41,42].
Recent work by Cohen et al. has demonstrated 
clinical evidence of parietal dysfunction in those 
Table 1. Budapest diagnostic criteria†.
Category Sign/symptom
Sensory Allodynia (pain to light touch and/or temperature sensation and/or deep somatic 
pressure and/or joint movement) and/or hyperalgesia (to pin prick)
Vasomotor Temperature asymmetry and/or skin color changes and/or skin color asymmetry
Sudomotor/edema Edema and/or sweating changes and/or sweating asymmetry
Motor/trophic Decreased range of movement and/or motor dysfunction (weakness, tremor, 
dystonia) and/or trophic changes (hair, nail, skin)
†For further information on the Budapest diagnostic criteria, please see [23]. 
Adapted with permission from [72].
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with chronic (1–18 years) CRPS [43]. This study 
was prompted by patient reports of problems with 
word and number order, both written and verbal. 
Standardized clinical parietal function tests 
provided objective evidence of finger agnosia, 
stereognosis, dysgraphesthesia, conduction 
aphasia, right/left disorientation and agraphia 
in a cohort of 22 CRPS patients. The extent 
and degree of allodynia exhibited in a patient 
strongly correlated with the number of failed 
parietal tests; in other words, those with the more 
severe allodynia exhibited more aberrant parietal 
function. The findings of this study corroborate 
well with previous clinical and imaging studies 
demonstrating disturbances in parietal cortex 
function in those with chronic CRPS [27,28,44–48]. 
As the parietal cortex is important for the 
assimilation of sensory and motor information 
to determine the level of perceived threat to 
the body, it is not surprising that those with 
CRPS present with high levels of anxiety and 
an overriding fear of touch to their affected limb. 
This fear-related response will be reflected by 
changes in autonomic regulation, and therefore 
autonomic pathway activity [49]. It has recently 
been observed that visual stimuli can also 
impact on autonomic function in those with 
chronic CRPS [50]. This study was prompted by 
clinical reports from patients that their vision 
appeared to be affected by their CRPS, although 
ophthalmological investigations failed to 
identify objective pathology. Using laser Doppler 
flowmetry, an asymmetrical pattern of response 
was identified (with significant variation in 
autonomic response between the affected and 
contralateral limbs) when those with CRPS 
viewed a Necker cube. A Necker cube is a bistable 
3D object that appears to tilt in two different 
directions, depending on the viewer’s mental 
vantage point (Figure 3). Processing this visual 
illusion is known to employ the dorsal, rather 
than the ventral, stream of the visual pathway 
[51]. This evolutionary-older pathway involves 
processing within the parietal lobe and visual 
areas, and is thought to be concerned with 
orienting oneself to an object and its location 
in extrapersonal space. Of the total cohort 
of patients (n = 30), 33.5% had asymmetric 
vasomotor responses when viewing the Necker 
cube, and all of the participants experienced 
increased pain as they looked at the image. All 
age- and gender-matched healthy controls in 
this study demonstrated a normal homologous 
symmetrical pattern of response and there were 
no reports of pain. This study provides direct 
evidence for the close relationship between pain, 
sensory processing and autonomic function, and 
builds on previous work that also demonstrated 
the generation of new sensory perceptions, 
including pain, when patients with chronic 
CRPS viewed a Necker cube [52].
The breadth and depth of signs and symptoms 
in chronic CRPS are only just starting to 
unravel, but evidence suggests there may be 
widespread systemic consequences of living 
with this condition for a protracted period of 
time [53]. Furthermore, symptoms may spread to 
affect other limbs and this commonly occurs in 
Figure 1. Acute complex regional pain 
syndrome with hyperemia, swelling and 
glossy skin. 
Reproduced from [6] with permission from 
Elsevier.
Figure 2. Complex regional pain syndrome in 
the persistent, chronic form.
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an ipsilateral or contralateral pattern and rarely 
occurs diagonally [54]. Spreading of symptoms 
to one or more limbs is commonly associated 
with a younger age at condition onset and a 
higher incidence of movement disorders [54]. 
‘Contiguous spread,’ the slow but significant 
spread of symptoms in the limb originally 
affected, is most commonly observed [55]. 
The individual with chronic CRPS presents 
with a highly complex clinical picture, which 
requires time and sensitivity on the part of the 
clinician to fully comprehend. Commonly, 
the healthcare setting is ‘time poor’, and this 
patient is frequently taking a large number of 
pharmacological agents with side effects that 
may add further complications to an already 
unclear picture. In addition, the patient may 
have previously repeated their medical history 
to multiple healthcare practitioners and may 
be concerned that their ever-increasing list of 
problems may be interpreted as psychosomatic 
in origin, thus raising their anxiety levels. This 
combination of factors can result in a suboptimal 
starting point for the design of a therapeutic 
care pathway, hence the recommendation is to 
identify the condition early and start treatment 
promptly with the aim of avoiding long-term 
problems [1–3]. However, if CRPS is recognized 
early, can we really prevent it from progressing 
to this chronic form?
Which rehabilitation strategies should be 
implemented once CRPS is diagnosed?
Ideally, if CRPS were suspected, a prophylactic 
intervention would be delivered to reduce 
the requirement for rehabilitation strategies. 
Vitamin C has been shown to provide some 
protective benefit if taken at 500- or 1500-mg daily 
doses for 50 days immediately post wrist fracture 
[56,57]. To date, this is the only intervention that has 
been identified that may reduce the risk of CRPS 
post trauma and as it is an innocuous intervention, 
it is a low-risk option that may provide some 
protection. The additional advantage of Vitamin 
C is that it can be commenced before a diagnosis 
of CRPS has been confirmed [56,57]. As CRPS 
is a diagnosis of exclusion – that is, there is no 
other diagnosis that better explains the signs and 
symptoms [23], it can be particularly challenging 
to determine when pain and edema from trauma 
has progressed to the signs and symptoms of 
CRPS. The Atkins [58] and Veldman criteria [20], 
which predated the current Budapest criteria [23], 
were developed within an orthopedic setting. 
However, comparison of the Atkins criteria with 
more recent diagnostic criteria suggests there are 
no gross differences, just a slight variation in the 
assessment of pain [59]. Therefore, current criteria 
should be reliable for a post-fracture cohort.
Once CRPS has been diagnosed, a 
multidisciplinary approach is recommended 
[1–3], with current UK therapeutic guidelines 
suggesting this is delivered under four ‘pillars’ 
of care (education, pain relief, physical 
rehabilitation and psychological intervention) 
[3]. The aim of medication at this stage is to 
facilitate engagement with, and movement of, 
the CRPS affected limb. Psychological support 
and a clinical team trusted by the patient can 
further enable the patient to achieve this. The 
UK guidance extends the current International 
Association for the Study of Pain algorithm of 
three pathways of care (psychological treatment, 
rehabilitation pathway and interventional 
pain management) with the fourth pillar of 
education. Evidence suggests that patients are 
keen to be well informed about their condition 
from a reliable source [60]. Those with chronic 
CRPS have described how increasing their levels 
of understanding of the condition provides 
reassurance that they are not alone and can help 
to normalize what are often unsettling CRPS 
symptoms [60]. 
In recent years, the pillar of physical 
rehabilitation has developed considerably. A 
number of innovative therapies have emerged that 
have been inspired by imaging evidence of a highly 
plastic, and therefore potentially modifiable, 
CNS [61]. In particular, the evidence of a positive 
correlation between the degree of perceived 
Figure 3. A Necker cube. The cube can be 
viewed in two different orientations depending 
on the viewer’s perspective. 
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pain and the extent of cortical reorganization 
in CRPS has encouraged researchers to devise 
ways to reverse these cortical changes in the hope 
of reducing pain and improving function [33,35]. 
The graded motor imagery program (GMIP) 
is one such intervention that seeks to improve 
motor planning in those with CRPS, thereby 
enhancing function and reducing pain [62]. The 
GMIP incorporates three distinct treatment 
steps: limb laterality recognition; imagined 
movements; and mirror visual feedback. In 
a recent systematic review of physiotherapy 
interventions for CRPS [63], strong evidence for 
the therapeutic benefits of GMIP was found, 
and it was recommended for inclusion in 
evidence-based rehabilitation programs. Three 
randomized controlled trials using GMIP have 
shown a reduction in pain and improvement in 
function in patients with early and chronic CRPS 
[62,64,65]. As described above, chronic CRPS is 
particularly problematic, and therefore GMIP is 
an exciting innovation. Clinical application of 
GMIP is still in its preliminary stages and, as yet, 
has failed to replicate the research evidence [66]. 
This is most likely due to the wide heterogeneity 
of the CRPS population and the labor-intensive 
nature of GMIP, meaning that it is not a practical 
option for all. Further work to identify which 
patient groups would most benefit from GMIP 
is still required. 
The final stage of the GMIP is mirror visual 
feedback (MVF). MVF is a form of visuomotor 
training and essentially provides a visual illusion 
whereby the reflection of the unaffected limb is 
superimposed onto the affected limb (Figure 4). 
It was originally devised as a standalone therapy, 
without the previous two stages of GMIP, and 
has been demonstrated to provide analgesic 
benefit, improve function and reverse thermal 
irregularities in those with early [67] and chronic 
CRPS [68]. Unlike GMIP, there is no definitive 
guidance or supporting evidence on the optimum 
frequency, duration of treatment sessions or 
recommended trial period for MVF. Treatment 
regimes tend to be devised between the patient 
and their therapist, informed by severity of 
symptoms, tolerance of the device and practical 
limitations [69]. Much work is still required to 
define a therapeutic ‘dose’ for MVF.
Physical rehabilitation is often difficult to 
initiate in those with CRPS due to the high levels 
of pain that movement commonly exacerbates. 
However, graded exposure therapy, a very recent 
innovation in the specialty of CRPS, encourages 
patients to progressively increase activities in a 
graded manner despite the pain [70,71], and may 
concurrently include the reduction, and eventually 
cessation, of analgesic medication [71]. The two 
studies conducted to date both used a single-
case design methodology and have demonstrated 
impressive results, with patients reporting dramatic 
reductions in pain intensity, pain-related fear, and 
improvements in function and muscle strength 
[70,71]. Intriguingly, in the most recent study by van 
de Meent and colleagues, only 18% of the total 
cohort (n = 20) had a reduction in kinesiophobia, 
which suggests that regular rehearsal of moving 
in the presence of pain does not automatically aid 
habituation [71]. This is a surprising finding and 
it will be interesting to see how this intervention 
develops when more data are available from 
larger trials of a longer duration. Evidence to date 
suggests this could be a promising new approach 
for CRPS rehabilitation. 
When to implement rehabilitation? 
As stated above, all current guidance on the 
treatment of CRPS promotes early diagnosis 
and intervention to optimize patient outcome 
[1–3]. However, this guidance, in terms of when 
to intervene, is based on expert clinical opinion 
and there are no definitive studies to inform the 
timing or sequence of interventions across the 
total therapeutic spectrum. With the majority 
of CRPS patients exhibiting only transient 
symptoms, and the lack of prognostic markers 
for those who will progress to the chronic form, 
the clinician walks a difficult line between 
‘watch and wait’ and ‘intervene aggressively and 
early’. As chronic CRPS has such devastating 
Figure 4. Mirror visual feedback for the upper or lower limb. The subject has their 
complex regional pain syndrome-affected (A) upper or (B) lower limb hidden from 
view behind the mirror while they view the reflected image of their unaffected limb. 
(B) Reprinted from [67] with permission from Oxford University Press.
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consequences on the individual, and is 
resource intensive for health and social care, 
clinical guidelines currently recommend close 
observation of patients in the early stages of the 
condition, with rapid referral to specialist care 
if the patient is failing to progress or symptoms 
are worsening [3]. 
Much research is still required to determine 
the temporal aspects of CRPS care. Future 
work should include economic as well as health 
evaluations to ensure potentially expensive 
specialist resources are used in a timely manner 
to optimize patient outcome.
For a list of the limitations of this review, 
please see Box 1.
Conclusion & future perspective 
This article has considered the current challenges 
of delivering an evidence-based rehabilitation 
program for those with CRPS, but how are these 
challenges best addressed in the future?
Rare conditions, such as CRPS, need large 
networked consortia to generate the sample 
sizes required to make meaningful progress. 
The Netherlands-based TREND consortium 
have already demonstrated the efficacy of 
this approach [101]. Led by van Hilten, this 
national consortium worked with international 
collaborators to generate a vast body of research 
over an 8-year period. Their outputs significantly 
advanced our knowledge of the mechanisms and 
treatments of CRPS, and established a template 
for future research consortia. 
Many countries now have well-established 
national registers for CRPS and it is essential that 
these resources are linked on an international basis 
to maximize our research potential. The American 
patient charity (Reflex Sympathetic Dystrophy 
Syndrome Association) have recognized the 
advantages of this networked approach and 
currently fund a nascent international consortia 
that aims to define recovery from CRPS [102]. 
This type of collaborative working will ultimately 
help us to define biomarkers for CRPS that will 
ideally enable us to identify those at greatest risk 
of developing the chronic form. In the meantime, 
over the next 5–10 years we should be able to 
tailor interventions to specific phenotypes and 
define a more evidence-based pathway of care, 
dependent on presenting signs and symptoms. 
Much work is required to move toward this stage 
and it is essential to involve patients within this 
work; working with patients as experts in the field 
will ensure our research remains focused on what 
matters most to them. 
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